Home » Topics » Regulatory

Regulatory
RSS

Lercanidipine 20 mg approved in Europe

March 7, 2003

Oral tazarotene completes phase III studies

March 7, 2003

Myoview approved for assessment of left ventricular function

March 6, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

March 6, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Avandia label broadened in the U.S.

March 4, 2003

FDA approves Oxytrol for overactive bladder

March 3, 2003

Risperdal Consta approved in Spain

Feb. 28, 2003

FDA approval for Gliadel Wafer during initial surgery for primary malignant glioma

Feb. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...